Prothena Corp PLC (PRTA)

12.60 +0.13  +1.04% NASDAQ Aug 12, 20:00 USD

Prothena Debt to Equity Ratio:

0.00 for June 30, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Debt to Equity Ratio Chart

Export Data
Save Image
Print Image

Historical Debt to Equity Ratio Data

View and export this data going back to 2012. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2020 0.00
March 31, 2020 0.00
Dec. 31, 2019 0.00
Sept. 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
Dec. 31, 2018 0.00
Sept. 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
Dec. 31, 2017 0.00
Sept. 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
Dec. 31, 2016 0.00
Sept. 30, 2016 0.00
   
June 30, 2016 0.00
March 31, 2016 0.00
Dec. 31, 2015 0.00
Sept. 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
Dec. 31, 2014 0.00
Sept. 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
Dec. 31, 2013 0.00
Sept. 30, 2013 0.00
June 30, 2013 0.00
March 31, 2013 0.00
Dec. 31, 2012 0.00

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Benchmarks

Benchmarks
Alkermes PLC 0.26
Endo International PLC -11.66
Jazz Pharmaceuticals PLC 0.6694

Debt to Equity Ratio Range, Past 5 Years

Minimum 0.00 Sep 2015
Maximum 0.00 Sep 2015
Average 0.00
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.